Have a feature idea you'd love to see implemented?
Let us know!
BIOX Bioceres Crop Solutions Corp
Price (delayed)
$6.49
Market cap
$407.9M
P/E Ratio
324.5
Dividend/share
N/A
EPS
$0.02
Enterprise value
$642.26M
bioceres crop solutions corp., together with its subsidiaries, provides crop productivity solutions. the company operates through three segments: seed and integrated products, crop protection, and crop nutrition. the seed and
Highlights
Bioceres Crop Solutions's quick ratio has increased by 13% YoY and by 2.2% QoQ
The equity has grown by 3.5% YoY
The company's revenue rose by 9% YoY but it fell by 4.6% QoQ
The gross profit has grown by 3.7% YoY but it has contracted by 3% from the previous quarter
Bioceres Crop Solutions's EPS has plunged by 91% YoY and by 60% from the previous quarter
The net income has plunged by 89% YoY and by 55% from the previous quarter
Key stats
What are the main financial stats of BIOX
Market
Valuations
Earnings
Shares outstanding
62.85M
Market cap
$407.9M
Enterprise value
$642.26M
Price to earnings (P/E)
324.5
Price to book (P/B)
1.32
Price to sales (P/S)
0.92
EV/EBIT
15.81
EV/EBITDA
10.29
EV/Sales
1.46
Revenue
$441.1M
EBIT
$40.62M
EBITDA
$62.4M
Free cash flow
$14.13M
Per share
Balance sheet
Liquidity
EPS
$0.02
Free cash flow per share
$0.22
Book value per share
$4.92
Revenue per share
$7.02
TBVPS
$8.58
Total assets
$827.26M
Total liabilities
$481.23M
Debt
$266.63M
Equity
$309.48M
Working capital
$81.23M
Debt to equity
0.86
Current ratio
1.27
Quick ratio
0.93
Net debt/EBITDA
3.76
Margins
Efficiency
Dividend
EBITDA margin
14.1%
Gross margin
40.5%
Net margin
0.3%
Operating margin
9.1%
Return on assets
0.2%
Return on equity
0.5%
Return on invested capital
8.9%
Return on capital employed
7.6%
Return on sales
9.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BIOX stock price
How has the Bioceres Crop Solutions stock price performed over time
Intraday
-0.31%
1 week
-8.85%
1 month
0.93%
1 year
-48.16%
YTD
-52.73%
QTD
-17.53%
Financial performance
How have Bioceres Crop Solutions's revenue and profit performed over time
Revenue
$441.1M
Gross profit
$178.7M
Operating income
$39.94M
Net income
$1.47M
Gross margin
40.5%
Net margin
0.3%
BIOX's net margin has dropped by 91% year-on-year and by 57% since the previous quarter
The net income has plunged by 89% YoY and by 55% from the previous quarter
BIOX's operating margin is down by 10% YoY but it is up by 3.4% QoQ
The company's revenue rose by 9% YoY but it fell by 4.6% QoQ
Growth
What is Bioceres Crop Solutions's growth rate over time
Valuation
What is Bioceres Crop Solutions stock price valuation
P/E
324.5
P/B
1.32
P/S
0.92
EV/EBIT
15.81
EV/EBITDA
10.29
EV/Sales
1.46
Bioceres Crop Solutions's EPS has plunged by 91% YoY and by 60% from the previous quarter
The stock's price to earnings (P/E) is 43% more than its last 4 quarters average of 227.5
BIOX's P/B is 68% lower than its 5-year quarterly average of 4.1 and 43% lower than its last 4 quarters average of 2.3
The equity has grown by 3.5% YoY
BIOX's P/S is 46% below its 5-year quarterly average of 1.7 and 43% below its last 4 quarters average of 1.6
The company's revenue rose by 9% YoY but it fell by 4.6% QoQ
Efficiency
How efficient is Bioceres Crop Solutions business performance
BIOX's return on equity has dropped by 89% year-on-year and by 55% since the previous quarter
The ROA has shrunk by 88% YoY and by 50% QoQ
Bioceres Crop Solutions's ROS has decreased by 12% YoY but it has increased by 2.2% from the previous quarter
BIOX's return on invested capital is down by 7% year-on-year and by 5% since the previous quarter
Dividends
What is BIOX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BIOX.
Financial health
How did Bioceres Crop Solutions financials performed over time
BIOX's total assets is 72% higher than its total liabilities
Bioceres Crop Solutions's quick ratio has increased by 13% YoY and by 2.2% QoQ
BIOX's total liabilities is down by 4% QoQ
BIOX's debt is 14% smaller than its equity
BIOX's debt is up by 11% year-on-year
Bioceres Crop Solutions's debt to equity has increased by 8% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.